Certain anti-cancer medications also target healthy cells in addition to malignant cells. Read further on Dynamite News:
Lung adenocarcinoma is the most common type of lung cancer, accounting for the majority of cancer-related fatalities in the US. Read further on Dynamite News:
A recent study emphasises the potential of synthetic DNA constructs that, when combined with antibodies, direct the immune system to target malignant cells in particular. Read further on Dynamite News:
English
English
English
